In 2020, the pharmaceutical retail industry ushered in a great change!

[pharmaceutical network market analysis] with the strengthening of national supervision on the pharmaceutical industry, new policies emerge frequently in the pharmaceutical industry, and a series of significant changes have occurred in the pharmaceutical retail industry Both the pharmaceutical research and development enterprises and the production enterprises will face great challenges For example, in 2019, under the influence of a series of policies, such as the rectification of pharmacist's license, the ending of pharmacy trusteeship, the implementation of "4 + 7" pilot, and "centralized procurement", the industry concentration and chain rate increased rapidly, the number of pharmacies increased, the average number of single store service population decreased, and the intervention of e-commerce and capital power brought many variable factors to the development of the pharmaceutical industry In 2020, the pharmaceutical retail industry ushered in a great change! Now that we have officially entered 2020, what will be the specific changes in the pharmaceutical retail industry? The growth of terminal market is slow, and the trend of centralized purchase is obvious China's drug terminals are roughly divided into three major terminal six markets, namely, public hospitals, retail pharmacies, public primary health care, excluding private hospitals, village clinics and private clinics Data shows that in the first half of 2019, the sales volume of China's drug terminal market was 908.7 billion yuan, a year-on-year growth of 5.8%, less than the 6.9% growth rate in 2018 From previous data, the sales growth of China's drug terminal market slowed down year by year In 2020, under the irresistible trend of retail drugstore reform, the phenomenon of "4 + 7" centralized purchase leading to different prices of the same drug may be solved "4 + 7" redefines the pharmaceutical retail industry Although the volume purchase mainly involves three links: production enterprise, distribution and hospital, which is not much related to drug retail enterprises, but with the continuous spread of "4 + 7" pilot, the drug price of the hospital may drop to the end, but the price of drugs supplied by the winning enterprise to the drugstore will not change or even increase, which will cause the drugstore to maintain the customer flow, or will refer to the hospital When the internal price reduces the store price, the gross profit of prescription drugs will further decline, destroying the original high gross profit system At present, the transmission effect of 4 + 7 is not very obvious, but it can be clear that the out of hospital market has become the focus of the pharmaceutical market In the future, many enterprises will pay close attention to the layout of retail channels In the future, the out of hospital retail market will also become the place of competition for pharmaceutical factories, commercial circulation enterprises and chain drugstores Internet plus, good medicine retail industry In recent years, the state has deepened the reform of medical and health fields, and has launched two new policies, including the system of "vote of the following systems", "drug ratio", "separation of medicine", "4+7" with quantity purchase, and encouragement of the development of "Internet plus medical health" With the introduction of a series of policies, the pharmaceutical and health industry is ushering in great changes in the industry and many new opportunities and new challenges At present, both online chain stores and online pharmaceutical e-commerce have begun to explore new operation modes with the help of Internet technology For example, since 2007, Yunnan Hongxiang Yixintang has been making great efforts to explore the innovative business model of the pharmaceutical retail industry with the help of Internet technology Among them, the deployment of SAP's Rep, Hana, hybrids, CRM and other systems and business platforms has become one of the important strategic layout of Yixintang In the future, the continuous rise of internet pharmaceutical channels will bring more new development opportunities for the transformation and upgrading of pharmaceutical retail industry and enterprises With the increasingly strict supervision, only the compliant operation can sell fake drugs in the long run and punish the inferior drugs severely From the construction of drug information traceability system, to coding requirements, to the action plan on accelerating the intelligent supervision of drugs, a series of operating instructions indicate that the State Food and drug administration is accelerating the supervision of the pharmaceutical industry, coupled with the revision of the drug administration law, the illegal cost of pharmacies will rise significantly In addition, inspired by the clarion call of "national classification and classification management system of retail pharmacies", the classification and classification management system of drugstores is in the stage of acceleration It is expected that by 2020, the classification and classification management system of retail pharmacies in most provinces and cities will be basically established, and the service level and industrial concentration will be improved in the future, which will be more compliant Therefore, in 2020, the pharmaceutical retail industry, whether it is single drugstore or chain drugstore, should always pay attention to the implementation of relevant policies, fully realize the national policy orientation, compliance management, and can be long-term Risk risk management and control will further strengthen the previously heated vaccine incidents, exposing serious drug safety problems, and a large number of supervisors are held accountable Although related enterprises were punished after the incident, it still caused serious social impact It is believed that in 2020, the state will continue to strengthen the control of potential risks, conduct multi-faceted troubleshooting of potential risks for drugs, medical devices and cosmetics, and carry out targeted centralized remediation activities, without blind spots or blind areas, and strictly adhere to the bottom line of drug safety Conclusion: on the whole, driven by the favorable policies of the new medical reform, the aging population structure, the continuous expansion of potential medical demand, and the enhancement of public health awareness, the improvement of self-care level and other factors, the growth of the pharmaceutical retail market will be booming It can be predicted that in the near future, the pharmaceutical retail industry will be playing the rallying call, and every pharmaceutical person in the trend will also usher in a bright future of personal development!